153 related articles for article (PubMed ID: 3496938)
21. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
Boeckler F; Leng A; Mura A; Bettinetti L; Feldon J; Gmeiner P; Ferger B
Biochem Pharmacol; 2003 Sep; 66(6):1025-32. PubMed ID: 12963489
[TBL] [Abstract][Full Text] [Related]
22. Dehydroepiandrosterone (DHEA) such as 17beta-estradiol prevents MPTP-induced dopamine depletion in mice.
D'Astous M; Morissette M; Tanguay B; Callier S; Di Paolo T
Synapse; 2003 Jan; 47(1):10-4. PubMed ID: 12422368
[TBL] [Abstract][Full Text] [Related]
23. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.
Irwin I; DeLanney LE; Forno LS; Finnegan KT; Di Monte DA; Langston JW
Brain Res; 1990 Oct; 531(1-2):242-52. PubMed ID: 1981162
[TBL] [Abstract][Full Text] [Related]
24. Partial protection from the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) by Pro-Leu-Gly-NH2(PLG; MIF-1).
Sheng JG; Xu DL; Yu HZ; Xu XR; Tang QM
Life Sci; 1987 May; 40(20):2007-10. PubMed ID: 2437428
[TBL] [Abstract][Full Text] [Related]
25. Effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on the regional distribution of brain monoamines in the rhesus monkey.
Pifl C; Schingnitz G; Hornykiewicz O
Neuroscience; 1991; 44(3):591-605. PubMed ID: 1754053
[TBL] [Abstract][Full Text] [Related]
26. Comparison of brain dopamine depletion induced by low-dose 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in young and aged rats.
Tsai YF; Tsai HW; Tai MY
Neurosci Res; 1994 Jul; 20(1):27-33. PubMed ID: 7984338
[TBL] [Abstract][Full Text] [Related]
27. Increased caudate dopamine turnover may contribute to the recovery of motor function in marmosets treated with the dopaminergic neurotoxin MPTP.
Rose S; Nomoto M; Kelly E; Kilpatrick G; Jenner P; Marsden CD
Neurosci Lett; 1989 Jul; 101(3):305-10. PubMed ID: 2505199
[TBL] [Abstract][Full Text] [Related]
28. Long-term effect of MPTP in the mouse brain in relation to aging: neurochemical and immunocytochemical analysis.
Date I; Felten DL; Felten SY
Brain Res; 1990 Jun; 519(1-2):266-76. PubMed ID: 1975765
[TBL] [Abstract][Full Text] [Related]
29. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.
Rioux L; Frohna PA; Joyce JN; Schneider JS
Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972
[TBL] [Abstract][Full Text] [Related]
30. Repeated administration of N-methyl-4-phenyl 1,2,5,6-tetrahydropyridine to rats is not toxic to striatal dopamine neurones.
Boyce S; Kelly E; Reavill C; Jenner P; Marsden CD
Biochem Pharmacol; 1984 Jun; 33(11):1747-52. PubMed ID: 6610420
[TBL] [Abstract][Full Text] [Related]
31. [Recovery of nigrostriatal and mesolimbic dopaminergic system following administration of ganglioside in MPTP-treated mice].
Date I; Asari S; Nishimoto A; Felten DL
No To Shinkei; 1990 Nov; 42(11):1035-40. PubMed ID: 2076347
[TBL] [Abstract][Full Text] [Related]
32. Dopamine turnover is upregulated in the caudate/putamen of asymptomatic MPTP-treated rhesus monkeys.
Pifl C; Hornykiewicz O
Neurochem Int; 2006 Oct; 49(5):519-24. PubMed ID: 16698121
[TBL] [Abstract][Full Text] [Related]
33. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine on dopamine metabolism in mouse and rat striatum.
Pileblad E; Fornstedt B; Clark D; Carlsson A
J Pharm Pharmacol; 1985 Oct; 37(10):707-11. PubMed ID: 2416901
[TBL] [Abstract][Full Text] [Related]
34. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
Jenner P; Marsden CD
J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
[TBL] [Abstract][Full Text] [Related]
35. Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines in heart, adrenal gland, retina and caudate nucleus of the cat.
Ambrosio S; Blesa R; Mintenig GM; Palacios-Araus L; Mahy N; Gual A
Toxicol Lett; 1988 Nov; 44(1-2):1-6. PubMed ID: 3263717
[TBL] [Abstract][Full Text] [Related]
36. Increased striatal dopamine turnover following acute administration of rotenone to mice.
Thiffault C; Langston JW; Di Monte DA
Brain Res; 2000 Dec; 885(2):283-8. PubMed ID: 11102582
[TBL] [Abstract][Full Text] [Related]
37. Persistent depletion of striatal dopamine in mice by m-hydroxy-MPTP.
Fuller RW; Hemrick-Luecke SK
Res Commun Chem Pathol Pharmacol; 1986 Aug; 53(2):167-72. PubMed ID: 3764080
[TBL] [Abstract][Full Text] [Related]
38. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
Fuller RW; Robertson DW; Hemrick-Luecke SK
J Pharmacol Exp Ther; 1987 Feb; 240(2):415-20. PubMed ID: 3100775
[TBL] [Abstract][Full Text] [Related]
39. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'CH3-MPTP)-induced degeneration of mesostriatal dopaminergic neurons in the mouse: biochemical and neuroanatomical studies.
Manaye KF; Sonsalla PK; Barnett G; Heikkila RE; Woodward DJ; Smith WK; German DC
Brain Res; 1989 Jul; 491(2):307-15. PubMed ID: 2765888
[TBL] [Abstract][Full Text] [Related]
40. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
Sundström E; Strömberg I; Tsutsumi T; Olson L; Jonsson G
Brain Res; 1987 Mar; 405(1):26-38. PubMed ID: 2882814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]